PHOSPHATE AND PHOSPHONATE DERIVATIVES OF 7-AMINO-5-THIO-THIAZOLO[4,5-D]PYRIMIDINES AND THEIR USE IN TREATING CONDITIONS ASSOCIATED WITH ELEVATED LEVELS OF CX3CR1 AND/OR CX3CL1
There is provided a compound of formula (I), wherein R1, R2, Q1 and formula (X) are as defined herein, which compounds are useful in the treatment of diseases and disorders associated with elevated levels of CX3CR1 and/or CX3CL1, in particular acute and/or chronic inflammation, eye diseases, lung di...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | There is provided a compound of formula (I), wherein R1, R2, Q1 and formula (X) are as defined herein, which compounds are useful in the treatment of diseases and disorders associated with elevated levels of CX3CR1 and/or CX3CL1, in particular acute and/or chronic inflammation, eye diseases, lung diseases, skin diseases, joint and/or bone diseases, autoimmune diseases, cardiovascular diseases, metabolic diseases, brain diseases, neurodegenerative diseases, pain, cancer, liver diseases, kidney diseases, gastrointestinal diseases, human immunodeficiency virus and mood disorders.
L'invention concerne un composé de formule (I), dans laquelle R1, R2, Q1 et la formule (X) sont tels que définis dans la description, lesdits composés étant utiles dans le traitement de maladies et de troubles associés à des niveaux élevés de CX3CR1 et/ou CX3CL1, en particulier une inflammation aiguë et/ou chronique, des maladies oculaires, des maladies pulmonaires, des maladies cutanées, des maladies articulaires et/ou osseuses, des maladies auto-immunes, des maladies cardiovasculaires, des maladies métaboliques, des maladies cérébrales, des maladies neurodégénératives, la douleur, le cancer, des maladies hépatiques, des maladies rénales, des maladies gastro-intestinales, le virus de l'immunodéficience humaine et des troubles de l'humeur. |
---|